= Solution
\b[For an adult with established <obsessive-compulsive disorder>, the core psychological recommendation is <cognitive behavioral therapy> including <exposure and response prevention>; an <SSRI> is another established first-line option, with choice and combination guided by impairment, preference, previous response and clinical assessment.] There is no single justified prescription from the diagnostic label alone. A recommendation should connect the maintaining process to an intervention and then examine randomized evidence, tolerability and generalizability.
Assessment first distinguishes recurrent <obsessions> and <compulsions> from ordinary unwanted thoughts, practical precautions and other causes of repetitive behavior. <Compulsions> may be covert mental reviewing or neutralizing rather than visible washing or checking. Relevant information includes time consumed, distress, interference, avoidance, insight, concurrent <depression>, current risk, physical consequences, family responses and previous treatment. A baseline measure such as the <Yale-Brown Obsessive Compulsive Scale> can track severity, but neither a score nor the content of an intrusive thought replaces an assessment of its meaning and associated behavior.
<Paul Salkovskis>'s cognitive-behavioral formulation distinguishes an intrusion from its appraisal and the responses that can maintain it. An unwanted thought is interpreted as unusually significant or as creating <inflated responsibility> for preventing harm. Ritualizing, reassurance or avoidance briefly reduces distress. This <negative reinforcement> makes repetition more likely and prevents <learning> that the intrusion can pass without neutralization. Attempting perfect certainty can generate still more checking. The target is therefore the response to the intrusion and its appraisal, not a requirement to eliminate all unwanted thoughts before normal life can resume.<Obsessional-compulsive problems: A cognitive-behavioural analysis by Paul Salkovskis>[1985, responsibility appraisals, cognitive-behavioral model and case material]{ref}
In <exposure and response prevention>, therapist and patient agree a hierarchy of relevant situations and feared predictions. Exposure brings the person into contact with an appropriate trigger; response prevention means refraining from the ritual, including covert neutralization and reassurance that would perform the same function. Tasks may be in vivo or, where appropriate, imaginal. For checking, the <learning> target is tolerating ordinary uncertainty without repeated checking, rather than obtaining an absolute guarantee that nothing bad can happen. Tasks are collaborative and concern ordinary, acceptable uncertainty; genuine hazards are not deliberately created.
The rationale includes both <learning> that distress can change without ritualizing and testing whether <compulsions> are necessary. <Habituation> can occur, but a reduction in fear within every session is not the sole criterion of <learning>. An <inhibitory learning> interpretation emphasizes a new association between the cue and a nonritualized outcome that competes with the old threat expectation. Varying situations and planning practice between sessions can support retrieval of that <learning> outside the therapy room. Cognitive procedures address overestimation of threat, responsibility and the assumed significance of thoughts; they should facilitate behavioral <learning> rather than become endless reassurance.<Maximizing exposure therapy: An inhibitory learning approach by Michelle G. Craske and others>[2014, inhibitory-learning rationale, expectancy violation and retrieval across contexts]{ref}
Randomized evidence supports this emphasis. <Edna B. Foa> and colleagues compared intensive exposure and ritual prevention, <clomipramine>, their combination and pill placebo in a trial with 122 adult entrants. All active conditions outperformed placebo, and exposure-based treatment performed better than <clomipramine> alone. Combining <clomipramine> with exposure did not clearly outperform exposure alone. This supports an effective psychological treatment, but does not establish that adding any medication is always useless: the comparison involved a particular drug, intensive expert-delivered exposure, and a particular treatment schedule. Medication could be blinded against placebo; psychological treatment could not be concealed from participants and therapists.<Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder by Edna B. Foa and others>[2005, randomized conditions and acute-treatment results]{ref}
An <SSRI> can be offered when preferred, when psychological treatment is inaccessible or difficult to engage with, or as part of combined care. Medication requires prescribing oversight, discussion of adverse effects, interactions and discontinuation, and a sufficient monitored trial before declaring nonresponse. Its effectiveness does not prove that an individual has a simple serotonin deficiency: changing a signaling system is different from establishing the original cause of a disorder.
The pre-examination <NICE> framework used stepped care: lower-intensity <CBT> including <ERP> for suitable mild impairment, a choice of more intensive <CBT> including <ERP> or an <SSRI> for moderate impairment, and combined <CBT>/<ERP> plus an <SSRI> for severe impairment. Inadequate response warrants review of diagnosis, treatment adequacy, engagement and comorbidity, followed by an agreed change or combination; persistent difficulty calls for specialist multidisciplinary assessment. These are severity-sensitive alternatives, not a demand that every adult start with combined treatment or that severity can be inferred from one alarming <obsession>.<Obsessive-compulsive disorder and body dysmorphic disorder: treatment by NICE>[2005 guideline, adult initial treatment and poor-response recommendations; original full guideline §§7.4.1–7.4.2]{ref}
For persistent symptoms despite an adequate serotonin-reuptake inhibitor trial, <Helen Blair Simpson> and colleagues randomized 100 adults to added exposure and ritual prevention, <risperidone> or placebo while continuing medication. At eight weeks, exposure-based augmentation produced more clinical response and minimal symptoms than either pill condition; <risperidone> did not outperform placebo in this trial. This is strong evidence to consider adequate <ERP> before routine antipsychotic augmentation in comparable patients. It is not proof that antipsychotics never help any subgroup, nor evidence that the result automatically generalizes to untreated first presentations.<Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder by Helen Blair Simpson and others>[2013, randomized augmentation trial and week-eight outcomes]{ref}
Practical delivery matters. <Family accommodation> can unintentionally maintain rituals; with agreement, carers can support ordinary activities without supplying repeated reassurance or completing <compulsions>. Outcomes should include functioning, valued activities and distress as well as symptom scores. Nonresponse should prompt examination of whether exposure actually occurred and whether subtle rituals continued, rather than blaming the person. A relapse plan identifies early warning signs and maintains independent practice. \b[The best-supported recommendation is accessible, competent <CBT>/<ERP>, with an <SSRI> or combined treatment when indicated by assessment and preference, and structured review rather than automatic escalation.]
Back to article page
